Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 741760 of 20,252 grants

Completed RESEARCH CENTERS
SPORE in Breast Cancer
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT: OVERALL Using the well-established framework of a very active and strong multidisciplinary Vanderbilt-Ingram Cancer Center (VICC) Breast Cancer Program th...

$8.96M
USD
Completed OTHER RESEARCH-RELATED
The RUNX1 Research Program 8th Annual Scientific Conference and Patient Meeting
NATIONAL CANCER INSTITUTE Runx1 Foundation United States 2024 – 2025

PROJECT SUMMARY The main goal of the RUNX1 Research Program 8th Annual Scientific Conference and Patient Meeting is to create a dynamic convening in order to foster collaboration a...

$252K
USD
Completed RESEARCH CENTERS
Strengthening Research, Training and Outreach Capacity in Huntsman Cancer Institute's Mountain West Service Area
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2025

Project Summary/Abstract Huntsman Cancer Institute (HCI) at the University of Utah is the only NCI-designated Comprehensive Cancer Center in the Mountain West (Idaho, Montana, Neva...

$2M
USD
Completed RESEARCH CENTERS
Cancer Center Administration
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2025

ADMINISTRATION ABSTRACT Huntsman Cancer Institute (HCI) Administration supports the Cancer Center’s mission to provide excellence in innovative basic, translational, population sci...

Completed RESEARCH CENTERS
Evaluation of the tumor microenvironment in serous uterine cancers
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2025

PROJECT SUMMARY This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 24-044. Uterine cancer (UC) is the fourth most common...

$1.92M
USD
Active NON-SBIR/STTR RPGS
Combination Therapies Targeting Insulin Signaling in Endometrial Cancer
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2028

PROJECT SUMMARY/ABSTRACT Endometrial cancer is the most common gynecologic malignancy in the developed world, and its incidence and mortality rate are increasing due, in part, to t...

$5.08M
USD
Active NON-SBIR/STTR RPGS
Rac guanine nucleotide exchange factors in lung cancer
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2024 – 2027

ABSTRACTKRAS and EGFR mutations are the most prevalent genetic alterations detected in human lung adenocarcinomas, and play essential roles in malignant transformation and disease...

$4.59M
USD
Active OTHER RESEARCH-RELATED
Tumor Microenvironment Determinants of TKI Response in Oncogene-Driven Lung Cancer
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2029

1 Research: Tyrosine kinase inhibitors (TKIs) such as alectinib have transformed survival outcomes for patients 2 newly diagnosed with anaplastic lymphoma kinase (ALK) positive non...

$2.79M
USD
Active OTHER RESEARCH-RELATED
Investigating CD4+ T cell memory in cancer immunotherapy
NATIONAL CANCER INSTITUTE Washington University United States 2024 – 2028

Project Summary/Abstract This proposal encompasses a 5-year research and training plan to support the transition of Dr. Wattenberg to an independent research career. Dr. Wattenberg...

$1.79M
USD
Active OTHER RESEARCH-RELATED
New Proteomics Approaches to Study the Full Human Kinome, Inhibitor Resistance, and Kinase Degraders
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2024 – 2027

Project Abstract Protein kinases constitute one of the largest enzyme families in humans, and their aberrant and carcinogenic function in a vast array of cancers is well known. How...

$2.12M
USD
Active NON-SBIR/STTR RPGS
Optical Genome Mapping As a Novel Diagnostic Approach in Pediatric Brain Tumors
NATIONAL CANCER INSTITUTE Lurie Children'S Hospital of Chicago United States 2024 – 2029

ABSTRACT One of the greatest advances in pediatric brain tumor management has been the incorporation of tumor molecular findings in the diagnosis, prognostic stratification, and tr...

$6.99M
USD
Active NON-SBIR/STTR RPGS
Identifying factors associated with prostate cancer progression and survival in African American men: The RESPOND Cohort
NATIONAL CANCER INSTITUTE University of Southern California United States 2024 – 2029

African American (AA) men have a >80% higher incidence and are more than twice as likely to die from prostate cancer (PCa) than white men. The reasons for the high burden relati...

$16.2M
USD
Completed OTHER RESEARCH-RELATED
Puerto Rico Cancer Research Meeting
NATIONAL CANCER INSTITUTE Universidad Central Del Caribe United States 2024 – 2025

PROJECT SUMMARY The Puerto Rico Cancer Research Meeting (PRCRM), hosted by Universidad Central del Caribe – School of Medicine (UCC-SOM), aims to bridge the gap in cancer research...

$60K
USD
Active NON-SBIR/STTR RPGS
Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients with Acute Myeloid Leukemia
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Overview: The goal of this study is to examine the efficacy of a novel digital application (app) for improving quality of life (QOL) and psychological outc...

$5.91M
USD
Active TRAINING, INDIVIDUAL
Cognition, Vascular Function, and Physical Activity in Colorectal Cancer Survivors
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2024 – 2026

Colorectal cancer (CRC) is the 3rd most common cancer in the United States for both male and females. Advancements in treatment options are successfully helping CRC survivors (CRCS...

$451.4K
USD
Active NON-SBIR/STTR RPGS
Transcriptional Reprogramming in Melanoma Plasticity
NATIONAL CANCER INSTITUTE Wistar Institute United States 2024 – 2029

Project Summary/Abstract This application focuses on advanced melanoma, a highly aggressive type of skin cancer that arises from the pigment-producing melanocytes of the body. Desp...

$6.15M
USD
Active NON-SBIR/STTR RPGS
Lipid-Rich Macrophages at the Tumor-Adipose Interface: A New Target for Locally-Invasive Prostate Cancer Therapy
NATIONAL CANCER INSTITUTE Endeavor Health Clinical Operations United States 2024 – 2026

SUMMARY Macrophages are important contributors to the biology of the tumor microenvironment. As tumors penetrate the prostatic capsule they invade a lipid-rich depot known as the p...

$4.33M
USD
Active NON-SBIR/STTR RPGS
Targeting Metabolic Vulnerabilities of Triple Negative Breast Cancer Stem Cells
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Triple negative breast cancer (TNBC) is the most aggressive subtype with increased propensity for metastasis and few treatment options. Mounting evidence s...

$4.75M
USD
Active NON-SBIR/STTR RPGS
Targeted Degradation of EGFR and HER2 in NSCLC
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2024 – 2029

Project Summary/Abstract Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase (RTK), is an oncogenic driver that is frequently overexpressed or mutated in non-small...

$5.04M
USD
Active NON-SBIR/STTR RPGS
Lung Cancer Screening: Cumulative Risk and Multilevel Impact of False Positive Findings
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2029

ABSTRACT The National Lung Screening Trial demonstrated the efficacy of lung cancer screening (LCS) with low-dose computed tomography in reducing 5-year lung cancer mortality by 20...

$6.58M
USD